15 mega blockbuster products showed outpatient prescriptions of more than 50 billion won

(Yakup Shinmoon)

Last year, 15 mega blockbuster products showed outpatient prescriptions of more than 50 billion won.

BMS's hepatitis B treatment 'Baraclude' which is first place in the market, recorded 158.6 billion won outpatient prescriptions, and MSD's diabetes drugs 'Januvia' recorded 104 billion won.

So there are two items whose sales exceeded more than 100 billion won.

T...